advertisement
Sun X 9
Showing records 1 to 9 | Display all abstracts from Sun X71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Sun J
ACS applied materials & interfaces 2017; 9: 7990-7999
71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Li S; Shao M
Oncotarget 2017; 8: 2816-2824
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Lei Y
ACS applied materials & interfaces 2017; 9: 7990-7999
71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Tang B
Oncotarget 2017; 8: 2816-2824
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Dai Z
ACS applied materials & interfaces 2017; 9: 7990-7999
71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Zhang A
Oncotarget 2017; 8: 2816-2824
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Liu X; Huang T
ACS applied materials & interfaces 2017; 9: 7990-7999
71181 The association between serum uric acid and glaucoma severity in primary angle closure glaucoma: a retrospective case-control study
Cao W; Sun X
Oncotarget 2017; 8: 2816-2824
71498 Sustained Release of Brimonidine from a New Composite Drug Delivery System for Treatment of Glaucoma
Wu J; Xu ZP; Sun X
ACS applied materials & interfaces 2017; 9: 7990-7999
